- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Price disconnect
Taiwanese Pharmaceuticals & Biotech Price disconnect
Results
7
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
7 companies
TTY Biopharm
Market Cap: NT$18.5b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$74.40
7D
-3.4%
1Y
-2.7%
Standard Chemical & Pharmaceutical
Market Cap: NT$11.1b
Manufactures and sells pharmaceutical products in Taiwan and internationally.
1720
NT$56.70
7D
0.4%
1Y
8.7%
Cenra
Market Cap: NT$4.8b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$32.85
7D
-1.6%
1Y
-2.4%
Allied Biotech
Market Cap: NT$2.3b
Engages in the manufacture and sale of carotenoids worldwide.
1780
NT$23.70
7D
2.6%
1Y
33.5%
TSH Biopharm
Market Cap: NT$1.9b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$49.65
7D
-2.6%
1Y
4.3%
Taiwan Advance Bio-Pharmaceutical
Market Cap: NT$855.0m
Operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.
4186
NT$9.50
7D
-0.4%
1Y
-7.8%
Bioray Biotech
Market Cap: NT$605.0m
Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.
7561
NT$18.65
7D
-8.8%
1Y
-23.6%